Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
Damaskos C, Garmpis N, Valsami S, Spartalis E, Antoniou EA, Tomos P, Karamaroudis S, Zoumpou T, Pergialiotis V, Stergios K, Michaelides C, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D.
Damaskos C, et al.
Anticancer Res. 2016 Oct;36(10):5019-5024. doi: 10.21873/anticanres.11070.
Anticancer Res. 2016.
PMID: 27798860
Review.